Gene expression analysis reveals HOX gene upregulation in trisomy 8 AML

Leukemia

Volumn 24, Issue 6, 2010, Pages 1239-1243

  Kok, C H ^a,b,c   Brown, A L ^b,c   Ekert, P G ^d,e   D'Andrea, R J ^a,b,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CENTRE FOR CANCER BIOLOGY   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA9; HOMEODOMAIN PROTEIN; HOXA PROTEIN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW CELL; CELL LINE; CHROMOSOME ABERRATION; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC REGULATION; HEMATOPOIESIS; HOX GENE; HUMAN; KARYOTYPE; KARYOTYPING; LETTER; LEUKEMOGENESIS; MICROARRAY ANALYSIS; MONONUCLEAR CELL; PRIORITY JOURNAL; TRISOMY 8; BONE MARROW; CHROMOSOME 8; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; TRISOMY; UPREGULATION;

BONE MARROW; CHROMOSOMES, HUMAN, PAIR 8; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRISOMY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954617002     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.85     Document Type: Letter

References (11)

1. Paulsson K, Johansson B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris) 2007; 55: 37-48. (Pubitemid 46217945)
2. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van D, Boer JM et al. Prognostically useful geneexpression profiles in acute myeloid leukemia. New Engl J Med 2004; 350: 1617-1628. (Pubitemid 38528701)
3. Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 2009; 94: 131-134.
4. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325-4336. (Pubitemid 35429670)
5. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007; 26: 6766-6776. (Pubitemid 47585101)
6. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7: 823-833. (Pubitemid 350006257)
7. Dorrance AM, Liu S, Yuan W, Becknell B, Arnoczky KJ, Guimond M et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J Clin Invest 2006; 116: 2707-2716. (Pubitemid 44511634)
8. Mullighan CG, Kennedy A, Zhou X, Radtke I, Phillips LA, Shurtleff SA et al. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia 2007; 21: 2000-2009. (Pubitemid 47299976)
9. Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M et al. Functional proteomic profiling of AML predicts response and survival. Blood 2009; 113: 154-164.
10. Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD et al. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res 2010; 70: 453-462.
11. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083-1094. (Pubitemid 47410272)